Petros Pharmaceuticals (PTPI) Revenue & Revenue Breakdown
Petros Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$5.82B
Latest Revenue (Q)
$1.39M
Main Segment (Y)
Medical Devices
Main Geography (Y)
United States
Petros Pharmaceuticals Revenue by Period
Petros Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $5.82B | 97068.48% |
| 2022-12-31 | $5.99M | -23.29% |
| 2021-12-31 | $7.81M | -18.29% |
| 2020-12-31 | $9.56M | -38.63% |
| 2019-12-31 | $15.58M | - |
Petros Pharmaceuticals generated $5.82B in revenue during NA 2023, up 97068.48% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Petros Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $1.39M | -481.28% |
| 2023-12-31 | $-364.25K | -121.75% |
| 2023-09-30 | $1.67M | -16.02% |
| 2023-06-30 | $1.99M | -20.81% |
| 2023-03-31 | $2.52M | 215.50% |
| 2022-12-31 | $798.10K | -154.75% |
| 2022-09-30 | $-1.46M | -134.82% |
| 2022-06-30 | $4.19M | 69.83% |
| 2022-03-31 | $2.47M | -384.28% |
| 2021-12-31 | $-867.16K | -140.42% |
| 2021-09-30 | $2.15M | -12.71% |
| 2021-06-30 | $2.46M | -39.70% |
| 2021-03-31 | $4.08M | 39.13% |
| 2020-12-31 | $2.93M | -15.45% |
| 2020-09-30 | $3.46M | 152.24% |
| 2020-06-30 | $1.37M | -23.35% |
| 2020-03-31 | $1.79M | -14.58% |
| 2019-12-31 | $2.10M | -51.97% |
| 2019-09-30 | $4.37M | 8.59% |
| 2019-06-30 | $4.02M | -20.97% |
| 2019-03-31 | $5.09M | - |
Petros Pharmaceuticals generated $1.39M in revenue during Q1 2024, up -481.28% compared to the previous quarter, and up 174.01% compared to the same period a year ago.
Petros Pharmaceuticals Revenue Breakdown
Petros Pharmaceuticals Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| Medical Devices | $3.54M | - | - |
| Medical Device Sales | - | $3.26M | $3.21M |
| Prescription Medication Sales | - | - | $4.61M |
Petros Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 23: Medical Devices (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medical Devices | $806.45K | $775.71K | $2.52M | $1.01M | $682.90K | - | - | - | - | - | - | - |
| Medical Device Sales | - | - | - | - | $779.77K | $854.34K | $940.40K | $755.55K | $767.88K | $807.83K | $874.96K | - |
| Prescription Medication Sales | - | - | - | - | - | - | $3.33M | $1.52M | $-1.62M | $1.38M | $1.65M | $3.20M |
Petros Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Medical Devices (100.00%).
Petros Pharmaceuticals Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| International | $1.30M | - | - |
| United States | $4.53M | $4.80M | $6.57M |
| Non Us | - | $1.19M | - |
Petros Pharmaceuticals's latest annual revenue breakdown by geography, as of Dec 23: United States (77.75%), and International (22.25%).
Quarterly Revenue by Country
| Country | Jun 24 | Mar 24 | Dec 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $1.11M | $1.18M | $2.37M | $2.16M | $538.96K | $-1.65M | $3.86M | $2.05M | $-1.18M | - | - | - |
| International | $316.04K | $209.96K | - | - | - | - | - | - | - | - | - | - |
| Medical Devices | - | - | - | $1.01M | - | - | - | - | - | - | - | - |
| Non Us | - | - | - | - | $259.14K | $268.86K | $371.08K | - | - | - | - | - |
| UNITED STATES | - | - | - | - | - | - | - | - | - | $1.86M | - | - |
| U | - | - | - | - | - | - | - | - | - | - | $2.19M | $3.70M |
Petros Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Jun 24: United States (77.77%), and International (22.23%).
Petros Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PTPI | Petros Pharmaceuticals | $5.82B | $1.39M |
| LFCR | Lifecore Biomedical | $128.26M | $35.70M |
| ALIM | Alimera Sciences | $80.75M | $23.01M |
| SBFM | Sunshine Biopharma | $39.85M | $9.30M |
| CPIX | Cumberland Pharmaceuticals | $39.55M | $9.85M |
| TKNO | Alpha Teknova | $36.68M | $9.61M |
| AGRX | Agile Therapeutics | $19.59M | $5.58M |
| SNOA | Sonoma Pharmaceuticals | $12.73M | $3.44M |
| GHSI | Guardion Health Sciences | $12.25M | $36.35K |
| EVOK | Evoke Pharma | $5.18M | $1.74M |
| ADMP | Adamis Pharmaceuticals | $4.76M | $9.06M |
| AKAN | Akanda | $2.16M | $762.61K |
| SXTC | China SXT Pharmaceuticals | $1.97M | $939.58K |
| LSDI | Lucy Scientific Discovery | $7.05K | $9.68K |
| SHPH | Shuttle Pharmaceuticals | - | - |
| PRFX | PainReform | - | - |
PTPI Revenue FAQ
What is Petros Pharmaceuticals’s yearly revenue?
Petros Pharmaceuticals's yearly revenue for 2023 was $5.82B, representing an increase of 97068.48% compared to 2022. The company's yearly revenue for 2022 was $5.99M, representing a decrease of -23.29% compared to 2021. PTPI's yearly revenue for 2021 was $7.81M, representing a decrease of -18.29% compared to 2020.
What is Petros Pharmaceuticals’s quarterly revenue?
Petros Pharmaceuticals's quarterly revenue for Q1 2024 was $1.39M, a -481.28% decrease from the previous quarter (Q4 2023), and a -44.84% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $-364K, a -121.75% decrease from the previous quarter (Q3 2023), and a -145.64% decrease year-over-year (Q4 2022). PTPI's quarterly revenue for Q3 2023 was $1.67M, a -16.02% decrease from the previous quarter (Q2 2023), and a 0% increase year-over-year (Q3 2022).
What is Petros Pharmaceuticals’s revenue growth rate?
Petros Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 74438.36%, and for the last 5 years (2019-2023) was 37277.71%.
What are Petros Pharmaceuticals’s revenue streams?
Petros Pharmaceuticals's revenue streams in c 23 are Medical Devices
What is Petros Pharmaceuticals’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Petros Pharmaceuticals was Medical Devices. This segment made a revenue of $3.54M, representing 100.00% of the company's total revenue.